Navigation Links
ULURU Inc. Announces First Order Of Altrazeal For European Launch
Date:9/20/2012

ADDISON, Texas, Sept. 20, 2012 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR), announced today the receipt of the first European order for the launch of Altrazeal® in Austria.

It is anticipated that Altrazeal® will be launched in Austria in October. Over the past 12 months Altrazeal® has been extensively clinically evaluated at the major wound care centers in Vienna by key opinion leaders. These evaluations have demonstrated the clinical benefits of Altrazeal® in chronic wounds and very importantly the potential to generate significant cost savings for the health care system.

Commenting on the launch of Altrazeal® in Austria, Helmut Kerschbaumer, Chairman of Melmed Holdings AG, stated, "We have conducted extensive pre-marketing activities to generate the necessary key opinion leader support not only in Austria but throughout Europe. The clinical and economic advantages that have been demonstrated are significant benefits that make Altrazeal® a unique product in the wound care market. Also, its ability to inhibit bacterial growth over an extended period when used with different antiseptics is considered a major marketing opportunity. The properties of Altrazeal® including extended wear time, reduced wound care provider treatment time and clinical outcomes make it an ideal product for the European market."

In addition to the activities in Austria there are ongoing programs throughout Europe designed to prepare for the launch of Altrazeal® in additional markets in early 2013. An advisory group with key opinion leaders from all major European countries has been assembled to assist and direct activities to position Altrazeal® for market success. Clinical programs are being developed to clearly demonstrate the economic advantages generated by the use of Altrazeal®

Kerry Gray, President and
'/>"/>

SOURCE ULURU Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ULURU Inc. Reports Second Quarter 2012 Financial Results
2. ULURU Inc. Announces Completion Of $2.2mil Convertible Debt Offering
3. United Therapeutics Announces Collaboration With Ascendis Pharma To Develop Self-Injectable Treprostinil For Pulmonary Arterial Hypertension
4. FDAnews announces Third Annual Pharmaceutical Labeling Summit
5. CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $6 Billion of Common Stock
6. PRN Physician Recommended Nutriceuticals announces partnership with Dr. Eric Donnenfeld and expansion in the New York City metropolitan area
7. InnoPharma, Inc., Announces U.S. FDA Approval of Acetylcysteine Solution, USP, 20% for Inhalation or Oral Administration
8. Specialty Pharmacy Certification Board Announces Inaugural Board of Directors
9. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
10. Golden Meditech Holdings Limited Announces Updates on Medical Devices Subsidiary Latest Development
11. Active Life Announces Launch of Next Generation BioDentTM for Life Science Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces that ... to the announced tender offer for all of the outstanding shares ... of the waiver, the transaction is no longer conditional on OFT ... 24, 2014 following the currently scheduled expiration time, subject to the ...
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. ... a U.S. provisional patent application concerning composition of matter, ... achieve targeted tumor cell death.  This ... noncoding double stranded RNA molecules (VSRNAs) which interfere with ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... , LACHEN, Switzerland , Jan. ... of plasma products in the world, today announced that it has received ... Food and Drug Administration (FDA). The approval was granted for the ... bleeding episodes in patients with severe von Willebrand disease (VWD) as well ...
... , SUNNYVALE, Calif. , Jan. 13 ... of radiosurgery, today announced that it will report results for its fiscal second ... 4, 2010 after the market closes. , A conference call to review ... EST and will be hosted by Euan S. Thomson , Ph.D., ...
Cached Medicine Technology:Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease 5Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease 6Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010 2Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010 3
(Date:7/9/2014)... poor printing on prescription labels handed out by ... errors in taking medication, according to new research ... National Institute for the Blind)., The study, published ... found that labels on prescription medications dispensed by ... for legibility. , By simply following recommended guidelines ...
(Date:7/9/2014)... , , , , , ... , , , ... weapon was an SA80 assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet... , ... , , , , ... , , , , ...
(Date:7/9/2014)... allergic diseases has risen dramatically in Western societies. One ... to microorganisms and have fewer infections than previous generations, ... study by researchers at Sahlgrenska Academy, University of Gothenburg, ... maturation of the immune system in relation to allergic ... of the Vstra Gtaland Region, half of them on ...
(Date:7/8/2014)... Older kidney donors enjoy similar longevity and cardiovascular health ... study published in the American Journal of Transplantation ... individuals considering donation and the transplant professionals caring for ... donation by individuals aged 55 years and older has ... kidney disease, and heart disease, the removal of a ...
(Date:7/8/2014)... Defense Advanced Research Projects Agency (DARPA) awarded Lawrence ... to develop an implantable neural device with the ... brain to help restore memory, DARPA officials announced ... understanding that memory is a process in which ... information, store it and retrieve it. Certain types ...
Breaking Medicine News(10 mins):Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7Health News:Study finds kidney donation safe for healthy older adults 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 3
... New research shows that individual exacerbations in chronic ... of repeat exacerbations, even after five days of ... where each exacerbation can drive the progression of ... are not random has important implication for the ...
... JEFFREY KRONSON, M.D. CHALLENGES NOTION THAT CUTTING IS THE ... River,s "Men Are Stupid And They Like Big Boobs" ... effort to coerce women into plastic surgery to be ... remains convinced that younger women and men are getting ...
... meet weight-linked healthcare needs of 6.2 million kids , , ... called a "landmark agreement," former President Bill Clinton and ... a national initiative on childhood obesity, aimed at getting ... visits to both primary care physicians and dietitians. , ...
... KALAMAZOO, Mich., Feb. 19 Esphera3 International (E3I) ... on the principles of "Patient Focused Care." Currently ... encompasses all aspects of a partnered care health ... resource management and financial operations of healthcare.E3I and ...
... 19 Leading Veterans organizations this week ... early lung cancer detection research at the ... strongly supported by the Lung Cancer Alliance ... organizations issue the "Independent Budget" request to ...
... There are approximately 7.1 million injury-related emergency department (ED) ... States annually, according to the Centers for Disease Control ... universities, including the University of Missouri, found that young ... to have been reported to Child Protective Services (CPS) ...
Cached Medicine News:Health News:Exacerbations in COPD: One thing leads to another 2Health News:Exacerbations in COPD: One thing leads to another 3Health News:Joan River's New Plastic Surgery Promotion Book is Out of Sync With What Women Really Need to Hear About Going Under The Knife! 2Health News:Bill Clinton, Health Groups to Tackle Childhood Obesity 2Health News:Esphera3 International Founded on 'Patient Focused Care' 2Health News:Veterans Organizations Call For Early Lung Cancer Detection Research 2Health News:Researchers recommend increased physician awareness to reduce injuries and neglect in children 2
Designed for the effective positioning of patients during spinal surgery, the frame gives the surgeon a remarkably simple and versatile surgical tool....
High temperature loop tip cautery....
Low temp, micro fine tip, patented Aaron RAM cauteries....
6 mm, 45 degree upwards, detachable....
Medicine Products: